Brazilian health authorities have reported an increase in the number of cases of Severe Acute Respiratory Syndromes (SARS) in 22 states and the Federal District, where three out of every four detections were of COVID-19.
Brazil s National Health Surveillance Agency (Anvisa) has announced it had received this week the request for registration of a COVID-19 vaccine that uses recombinant protein technology.